This startup is focused on detecting diabetic retinopathy (DR) using deep learning algorithms. It captures the patient’s retina image, analyses it and presents a report out of it. It can be used to detect DR in less than a total of three minutes, which is way faster than humans. It is also striving to create early detection tools for TB, breast cancer and lung cancer with the help of its AI screening tool.
Company Info
- Founded
- 2016
- Website
- artelus.ai/
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Artelus?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.